NCT03458429View on ClinicalTrials.gov

Safety, Efficacy of FFP From Healthy Donors to Ameliorate Frailty and Enhance Immune Function in Older Individuals

PHASE1/PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 5, 2018

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2027

Conditions
Frailty
Interventions
DRUG

GMFFP

Granulocyte-Colony Stimulating Factor (G-CSF) Mobilized Fresh Frozen Plasma

Trial Locations (1)

33437

South Florida Bone Marrow/Stem Cell Transplant Institute DBA Maharaj Institute of Immune Regenerative Medicine, Boynton Beach

All Listed Sponsors
lead

Dipnarine Maharaj

OTHER